PHARMACEUTICAL COMPOSITION FOR COMBINATION THERAPY CONTAINING P53 ACTIVATOR AND C-MET INHIBITOR

摘要

Provided is a pharmaceutical composition for a combination therapy containing a p53 activator and a c-Met inhibitor as an active component. The pharmaceutical composition for the combination therapy expresses excellent synergistic effects and reduces an effective does of the p53 activator and the c-Met inhibitor, thereby enabling efficient treatment.